ABC00956RN

Mirtazapine EP Impurity F

Mirtazapine EP Impurity F is a structurally related degradation byproduct of the antidepressant mirtazapine, characterized by a substituted thiazole ring system with a piperazine side chain and a methoxyphenyl moiety. The compound features a secondary amine, an amide linkage, and aromatic heterocycles, differing from the parent drug by a methylene bridge oxidation to a hydroxyl group. This impurity arises via oxidative degradation under acidic conditions. It serves as an HPLC reference standard for quantifying process-related impurities in mirtazapine active pharmaceutical ingredients.

On Request
Molecular Formula C17H17N3O
Molecular Weight 279.3400
CAS Number 191546-97-1 โœ“ Verified
PubChem CID 15541753 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Mirtazapine
Lead Time On Request
IUPAC Name 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaen-14-one
Official Reference Standards
Std Catalog # Quantity Price
USP 1444252 โ†— 50 mg USD 813.00

๐Ÿ“ Synonyms

T6BQ3WH3L4 10-KETOMIRTAZAPINE 1,3,4,14b-Tetrahydro-2-methylpyrazino(2,1-a)pyrido(2,3-C)(2)benzazepin-10(2H)-one MIRTAZAPINE IMPURITY F [EP IMPURITY] MIRTAZAPINE IMPURITY F (EP IMPURITY) 1,3,4,14b-Tetrahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-10(2H)-one RefChem:437040 191546-97-1 10-Oxo Mirtazapine (Mirtazapine Impurity F) Mirtazapine EP Impurity F

๐Ÿ”ฌ Chemical Identifiers

CN1CCN2C(C1)C3=CC=CC=C3C(=O)C4=C2N=CC=C4
InChI=1S/C17H17N3O/c1-19-9-10-20-15(11-19)12-5-2-3-6-13(12)16(21)14-7-4-8-18-17(14)20/h2-8,15H,9-11H2,1H3
RZDFSDWHGNDESU-UHFFFAOYSA-N

Related Products